DongKoo Bio & Pharmaceutical Completes Ampoule Plant in Mongolia, Establishes Eurasian Export Hub
Expansion of Local Production Base and Utilization as Export Hub
Securing a Strategic Gateway for Overseas Market Entry
DongKoo Bio & Pharmaceutical announced on May 14 that it has held a completion ceremony for its ampoule manufacturing plant in Ulaanbaatar, Mongolia, and has officially begun local production. DongKoo Bio & Pharmaceutical is drawing attention as the first foreign pharmaceutical company in Mongolia to directly invest in a local pharmaceutical manufacturing facility, establishing a strategic base that integrates production, technology, and distribution.
In November 2023, DongKoo Bio & Pharmaceutical signed a memorandum of understanding (MOU) with Mongolian pharmaceutical company Munkhiin Tun LLC to establish the ampoule manufacturing plant. Since the first half of last year, the company has participated as a shareholder in the MDM (Munkhiin-DongKoo-MEIC) joint venture, jointly promoting the project. The local plant goes beyond simple contract manufacturing to include technology transfer and joint investment. It is establishing itself as a model that contributes to strengthening the foundation for self-sufficiency in the Mongolian pharmaceutical market.
The newly established production facility will initially focus on supplying the Mongolian domestic market. In the future, DongKoo Bio & Pharmaceutical plans to obtain Korean GMP certification and gradually expand the facility as an export hub to Africa, CIS, and some ASEAN countries. The company is also considering re-importing some of the products produced at the plant back to Korea for domestic distribution.
DongKoo Bio & Pharmaceutical defines Mongolia as a strategic "gateway" for overseas market expansion and plans to utilize this production facility as a key base connecting the Asian and Eurasian regions.
Mongolia is a market with a high dependence on pharmaceutical imports and increasing trust in Korean pharmaceuticals. By establishing localized production and supply chains, DongKoo Bio & Pharmaceutical can maximize its market entry effectiveness.
The ampoule plant was established through a three-party joint venture between DongKoo Bio & Pharmaceutical, Mongolian pharmaceutical company Munkhiin Tun LLC, and Mongolia's largest distribution company Mongol Em Impex Concern LLC (MEIC). Each company has agreed to take on clearly defined roles based on their respective expertise to establish an efficient operational system.
DongKoo Bio & Pharmaceutical is responsible for the transfer of core technologies required for pharmaceutical manufacturing and overall quality control, introducing global production standards to the local facility. Munkhiin Tun LLC leads production and local operations, leveraging its experience in pharmaceutical manufacturing in Mongolia, as well as its plant site and facility management capabilities. MEIC is in charge of product supply and market expansion through its nationwide distribution network and logistics infrastructure.
With the organic collaboration of these three companies, each with expertise in technology, production, and distribution, it is expected that a stable, self-sufficient production and supply system can be established within the Mongolian pharmaceutical market.
Through this project, DongKoo Bio & Pharmaceutical is solidifying its position in the Mongolian market while enhancing global brand credibility and strengthening its foundation for overseas expansion. In the future, the company plans to expand exports to various countries centered on this production facility and to enhance its competitiveness in the international market based on its global-level quality management capabilities.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
Cho Yongjun, CEO of DongKoo Bio & Pharmaceutical, stated, "The completion of the ampoule plant will serve as a strategic stepping stone for expanding exports to Mongolia and neighboring countries, and will become a 'gateway' connecting DongKoo Bio & Pharmaceutical to the global market." He added, "We will continue to expand our overseas expansion strategy based on technological capabilities."
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.